Article citationsMore>>

Allen, D., Fischer, A., Bshouty, Z., Robinson, D.B., Peschken, C.A., Hitchon, C., El-Gabalawy, H., Meyers, M. and Mitroo, S. (2012) Evaluating Systemic Lupus Erythematosus Patients for Lung Involvement. Lupus, 21, 1316-1325. https://doi.org/10.1177/0961203312454343

has been cited by the following article:

• TITLE: Lung in Systemic Lupus Erythematosus: A Single-Center Experience

  AUTHORS: Maria do Socorro Teixeira Moreira Almeida, Catarina Fernandes Pires, João Vicente Moreira Almeida

  KEYWORDS: Systemic Lupus Erythematosus, Pulmonary Systemic Lupus Erythematosus, Autoimune Diseases

  JOURNAL NAME: Open Access Library Journal, Vol.9 No.9, September 19, 2022

  ABSTRACT: Introduction: Systemic lupus erythematosus (SLE) is the autoimmune disease with the highest prevalence of pulmonary involvement, which ranges from 20% to 90% of the patients, depending on the criteria employed in the cohorts being studied (symptomatology or histopathology). More than 50% of the patients develop pleuropulmonary manifestations at least once during the course of the disease; likewise, pleuropulmonary involvement has been associated with a higher rate of mortality. The purpose of this study is to determine the frequency of respiratory symptoms, and abnormal lung function in a sample of Brazilian patients with systemic lupus erythematosus (SLE). Methods: Retrospective study of 55 SLE patients from a single Rheumatology Unit in Brazil; the patients fulfilling the ACR criteria for SLE. Demographics and clinical characteristics were recorded and the patients were evaluated using chest X-rays, pulmonary function tests (PFTs), and HRCT of the chest to find out the pulmonary involvement. Results: Thirty-two patients had respiratory symptoms, 45 (82%) patients had abnormal lung function, 25 (45.4%) patients had abnormal computed tomography and 20 (36.4%) patients had abnormal chest X-ray. Conclusion: Respiratory symptoms and abnormal lung function are common in SLE. Clinicians should consider pulmonary evaluation among patients with systemic lupus erythematosus with and without respiratory symptoms.